治疗策略来击败前列腺癌异质性的治疗策略
Hossein Jadvar1, Amir Iravani2
1Division of Nuclear Medicine and Molecular Imaging Center, Departments of Radiology, Radiation Oncology and Urology, Keck School of Medicine, University of Southern CA, Los Anegles, CA, USA; USC Norris Comprehenisve Cancer Center, Keck School of Medicine, University of Southern CA, Los Anegles, CA, USA; Department of Biomedical Engineering, Viterbi School of Engineering, University of Southern CA, Los Angeles, CA, USA.
Seminars in nuclear medicine
|December 19, 2025
概括
转移性前列腺癌的异质性驱动疾病的进展和治疗耐药性. 个性化组合策略对于持久的疗效至关重要,特别是在放射性药物治疗中.
科学领域:
- 在瘤学瘤学.
- 医学物理 医学物理
背景情况:
- 转移性前列腺癌表现出显著的患者内和患者间异质性.
- 这种异质性使治疗复杂化,导致耐药性和失败.
研究的目的:
- 审查转移性前列腺癌异质性的要素.
- 通过放射性药物治疗提出克服治疗挑战的策略.
主要方法:
- 转移性前列腺癌异质性的文献综述.
- 分析放射性药物治疗中的挑战.
主要成果:
- 异质性是一种动态的,多因素的过程.
- 需要结合的,针对患者的具体方法.
结论:
- 了解瘤生物学是有效治疗的关键.
- 放射性药物治疗需要量身定制的策略来对抗异质性,以获得持久的临床疗效.
关键词:
阿尔法阿尔法阿尔法阿尔法阿尔法这是BetaBetaBetaBetaBeta.癌症 癌症 癌症 癌症异质性 异质性 异质性在PSMA上,PSMA可以在PSMA上进行交易.前列腺前列腺前列腺放射性药物 放射性药物是一种放射性药物.治疗疗法 治疗疗法更多相关视频
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K


